Related Experiment Videos

Persistent hyperinsulinaemic hypoglycaemia of infancy: case report

S Semiz1, I Bircan, S Akçurin

  • 1Department of Paediatrics, Pamukkale University, School of Medicine, Denizli, Turkey.

Insights

Persistent hyperinsulinaemic hypoglycaemia of infancy is a rare condition. This case study details a successful subtotal pancreatectomy and octreotide treatment for a neonate with this challenging diagnosis.

Area of Science:

  • Pediatric Endocrinology
  • Neonatal Medicine
  • Metabolic Disorders

Background:

  • Persistent hyperinsulinaemic hypoglycaemia of infancy (PHI) is the most common cause of persistent neonatal hypoglycemia.
  • PHI presents significant long-term management challenges due to recurrent hypoglycemia.

Observation:

  • A male neonate presented with recurrent convulsions and lethargy at three months old.
  • Initial investigations revealed severe hypoglycemia (24 mg/dl) with inappropriately high insulin levels, ketonuria absence, and high glucose infusion requirements.
  • Despite maximal medical management including prednisone, diazoxide, and octreotide, normoglycemia was not achieved.

Findings:

  • A diagnosis of persistent hyperinsulinaemic hypoglycaemia of infancy was confirmed.
  • A subtotal (80%) pancreatectomy was performed, followed by continued intermittent hypoglycemic episodes.
  • Post-operative management with low-dose octreotide effectively controlled residual hypoglycemia. Histology confirmed diffuse adenomatous hyperplasia (nesidoblastosis).

Implications:

  • Subtotal pancreatectomy combined with targeted medical therapy can be effective in managing severe PHI.
  • Early diagnosis and intervention are crucial for improving long-term outcomes in infants with PHI.
  • This case highlights the utility of octreotide in managing refractory hyperinsulinemic hypoglycemia post-surgery.

Related Concept Videos